Noubar Afeyan
Founder & CEO, Flagship Pioneering; Co-founder & Chairman, Moderna
Cambridge, Massachusetts
Invests in
Sectors:
Locations:
Min Investment:
$0.00Max Investment:
$0.00Target Investment:
$0.00
Skills
Education
- MI
- MU
Lists including Noubar
Investments
Prologue Medicines
Total Funding: $50M
Quotient Therapeutics
Total Funding: $50M
Generate Biomedicines
Total Funding: $640M
Alltrna
Total Funding: $160M
Empress Therapeutics
Total Funding: $50M
Metaphore Biotechnologies
Total Funding: $50M
Cellarity
Total Funding: $240M
Senda Biosciences
Total Funding: $210M
Apriori Bio
Total Funding: $50M
Tessera Therapeutics
Total Funding: $300M
Vesalius Therapeutics
Total Funding: $75M
Laronde
Total Funding: $490M
Omega Therapeutics
Total Funding: $130M
Axcella
Total Funding: $110M
Evelo Biosciences
Total Funding: $85M
Joule Unlimited Technologies
Total Funding: $140M
Seres Therapeutics
Total Funding: $69M
Moderna
Total Funding: $600M
WikiCell Designs
Total Funding: $10M
Sesen Bio
Total Funding: $55M
LS9
Total Funding: $75M
BIND Therapeutics
Total Funding: $31M
Ensemble Discovery
Total Funding: $30M
Adnexus
Total Funding: $56M
Affinnova
Total Funding: $15M
Work Experience
2000
Founder and CEO
2000
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. To date, Flagship has deployed over $3.4 billion in capital toward the founding and growth of its pioneering companies alongside more than $26 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 40 companies, including Denali Therapeutics (NASDAQ: DNLI), Foghorn Therapeutics (NASDAQ: FHTX), Generate:Biomedicines, Inari, Indigo Agriculture, Moderna (NASDAQ: MRNA), Omega Therapeutics (NASDAQ: OMGA), Sana Biotechnology (NASDAQ: SANA), Seres Therapeutics (NASDAQ: MCRB) and Tessera Therapeutics.
Member of Executive Committee, MIT Corporation
2016
2010
Co-Founder and Chairman
2010
Co-Founder and Chairman
2018
2018
Co-Founder and Board Member
2018
2024
Co-Founder and Board Member
2024
2021
Co-Founder and Chairman
2021
2022
Co-founder and Chairman
2022
2021
Founding Chairman
2021
2014
Co-Founder and Board Member
2014
Aurora Prize for Awakening Humanity is an annual international humanitarian award, which is initiated to recognize and express gratitude to those courageous individuals or organizations that impact on preserving human life and advancing humanitarian causes. It is awarded on behalf of the survivors of the Armenian Genocide and in gratitude to their saviors. The Aurora Prize ceremonies take place annually in Yerevan, Armenia starting from 24 April 2016. The laureate of the prize receives $100,000 grant as well as the opportunity to nominate organizations that inspired his or her work for a US $1,000,000 award (from Wikipedia).